Understanding Cosmetic Product and Ingredient Efficacy Claims in China
In recent years, ingredient-conscious consumers and the rapid growth of the functional skincare market have significantly reshaped the competitive landscape of the cosmetics industry in China. Consumers are increasingly demanding higher standards of product safety and efficacy. Since the implementation of the Cosmetics Supervision and Administration Regulation (CSAR) in 2021, China's National Medical Products Administration (NMPA) has introduced a series of regulatory documents, including the Cosmetic Classification Rules and Catalogs, as well as the Standards for Cosmetic Efficacy Claim Evaluation. Together with national, industry, and group standards, these regulations form a comprehensive framework that provides clear guidelines for substantiating cosmetic